.webp)
The global hemodialysis and peritoneal dialysis market size accounted for USD 112.40 billion in 2025 and is predicted to increase from USD 120.16 billion in 2026 to approximately USD 219.05 billion by 2035, expanding at a CAGR of 6.90% from 2026 to 2035. The market is driven by the increasing global prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD). This is directly fueled by an aging demographic and even rising rates of lifestyle-related conditions such as diabetes and hypertension.
The global CNS clinical trials market size was calculated at USD 8.65 billion in 2025 and is predicted to increase from USD 9.33 billion in 2026 to approximately USD 18.49 billion by 2035, expanding at a CAGR of 7.90% from 2026 to 2035. The market is driven by the rising global prevalence of neurodegenerative diseases, like Alzheimer's, Parkinson's, and Huntington's, combined with an aging global population.
The global decentralized clinical trials in neurology market size accounted for USD 1.48 billion in 2025 and is predicted to increase from USD 1.71 billion in 2026 to approximately USD 6.38 billion by 2035, expanding at a CAGR of 15.80% from 2026 to 2035. The increasing prevalence of neurological diseases and clinical trial activities are key growth factors for the market.
The global sevoflurane market size accounted for USD 1.15 billion in 2025 and is predicted to increase from USD 1.22 billion in 2026 to approximately USD 2.02 billion by 2035, expanding at a CAGR of 5.80% from 2026 to 2035. Growing surgical volumes, increasing healthcare expenditure, expansion of ambulatory surgical centers, rising prevalence of chronic diseases requiring surgical intervention, and advancements in anesthesia delivery systems are driving market growth.
The global brain health supplements and therapeutics market size was evaluated at USD 18.60 billion in 2025 and is anticipated to increase from USD 20.42 billion in 2026 to approximately USD 47.37 billion by 2035, expanding at a CAGR of 9.80% from 2026 to 2035. The market is driven by the rapid global aging population, which brings a rising prevalence of age-related cognitive and neurodegenerative diseases such as Alzheimer's and dementia.
The global cognitive assessment and brain health market size accounted for USD 9.40 billion in 2025 and is predicted to increase from USD 10.51 billion in 2026 to approximately USD 28.69 billion by 2035, expanding at a CAGR of 11.80% from 2026 to 2035. Rising neurological disease prevalence, growing awareness, and improved diagnosis are key factors driving growth in the market.
The US pathology laboratories market size was calculated at USD 103.84 billion in 2025 and is predicted to increase from USD 112.33 billion in 2026 to approximately USD 229.75 billion by 2035, expanding at a CAGR of 7.42% from 2026 to 2035. The market is growing due to strategic partnerships between hospitals and laboratory service providers and growing demand for oncology, neurology, autoimmune disease, and women's health testing.
The US anesthesia devices market size was calculated at USD 6.93 billion in 2025 and is predicted to increase from USD 7.41 billion in 2026 to approximately USD 14.20 billion by 2035, expanding at a CAGR of 7.44% from 2026 to 2035. The market growth is attributed to increasing surgical procedure volumes, expanding ambulatory care infrastructure, and continuous advancements in anesthesia delivery and patient monitoring technologies.
The US peptide therapeutics market size accounted for USD 21.24 billion in 2025 and is predicted to increase from USD 22.63 billion in 2026 to approximately USD 34.98 billion by 2035, expanding at a CAGR of 5.12% from 2026 to 2035. The market growth is attributed to rising obesity and diabetes prevalence, expanding peptide drug innovation, increasing GLP-1 therapy adoption, and growing investments in advanced peptide manufacturing technologies.
The US pharmaceutical stability and storage services market size accounted for USD 1.66 billion in 2025 and is predicted to increase from USD 1.76 billion in 2026 to approximately USD 2.92 billion by 2035, expanding at a CAGR of 5.81% from 2026 to 2035. The market is experiencing robust growth, driven by rising biologics and specialty drug development, expanding clinical trial activities, and stringent regulatory requirements for product quality and long-term stability testing throughout the drug development and commercialization lifecycle.
The US direct-to-consumer laboratory testing market size accounted for USD 1.23 billion in 2025 and is predicted to increase from USD 1.34 billion in 2026 to approximately USD 2.92 billion by 2035, expanding at a CAGR of 9.03% from 2026 to 2035. The market growth is attributed to rising demand for preventive healthcare, personalized diagnostics, at-home testing solutions, and increasing adoption of digital laboratory platforms.
The US regulatory affairs market size accounted for USD 4.31 billion in 2025 and is predicted to increase from USD 4.64 billion in 2026 to approximately USD 9.02 billion by 2035, expanding at a CAGR of 7.66% from 2026 to 2035. The market growth is attributed to increasing regulatory complexity, expanding healthcare innovation, rising FDA submission volumes, and growing adoption of AI-enabled regulatory technologies.
The US orthodontics market size accounted for USD 7.02 billion in 2025 and is predicted to increase from USD 7.87 billion in 2026 to approximately USD 20.63 billion by 2035, expanding at a CAGR of 11.40% from 2026 to 2035. The market is driven by rising demand for clear aligners and cosmetic dental procedures, increasing awareness of oral health, technological advancements in digital orthodontics, and escalating insurance coverage.
The US controlled substance market size accounted for USD 31.09 billion in 2025 and is predicted to increase from USD 32.74 billion in 2026 to approximately USD 52.11 billion by 2035, expanding at a CAGR of 5.70% from 2026 to 2035. The market growth is attributed to increasing prescription demand for pain management, ADHD, seizure disorders, and addiction treatment, supported by expanding healthcare access and stringent controlled-substance monitoring systems.
The US glioblastoma multiforme treatment market size accounted for USD 789.54 million in 2025 and is predicted to increase from USD 850.30 million in 2026 to approximately USD 1,634.84 million by 2035, expanding at a CAGR of 7.55% from 2026 to 2035. The market growth is attributed to the rising incidence of glioblastoma, expanding clinical research activity, and continuous advancements in precision oncology and targeted treatment technologies.
The global tylosin market size accounted for USD 920 million in 2025 and is predicted to increase from USD 969 million in 2026 to approximately USD 1,532 million by 2035, expanding at a CAGR of 5.30% from 2026 to 2035. The market is rapidly expanding due to the increasing demand for protein-rich foods, commercial poultry and swine farming, and mandatory rules to prevent bacterial infections in livestock amid rising meat consumption.
The US medical devices market size accounted for USD 191.20 billion in 2025 and is predicted to increase from USD 203.06 billion in 2026 to approximately USD 346.19 billion by 2035, expanding at a CAGR of 6.20% from 2026 to 2035. The market growth is attributed to increasing adoption of advanced medical technologies, expanding healthcare infrastructure, and continuous innovation in diagnostic and therapeutic devices.
The US rehabilitation equipment market size accounted for USD 5.19 billion in 2025 and is predicted to increase from USD 5.48 billion in 2026 to approximately USD 9.07 billion by 2035, expanding at a CAGR of 5.74% from 2026 to 2035. The market growth is attributed to increasing disability prevalence, rising rehabilitation service utilization, expanding geriatric populations, and growing adoption of advanced mobility and assistive rehabilitation technologies.
The US AI in medical imaging market size accounted for USD 716.22 billion in 2025 and is predicted to increase from USD 909.63 billion in 2026 to approximately USD 7,640.97 billion by 2035, expanding at a CAGR of 26.71% from 2026 to 2035. The market growth is attributed to rising adoption of AI-powered diagnostic tools, increasing imaging volumes, and expanding FDA-cleared imaging applications across healthcare systems.
The global implantable sensor orthopedic market size accounted for USD 1.06 billion in 2025 and is predicted to increase from USD 3.06 billion in 2026 to approximately USD 13.17 billion by 2035, expanding at a CAGR of 17.04% from 2026 to 2035. The increasing incidence of accidents and chronic diseases, along with further advancements in healthcare devices, support market growth.
The global ceftriaxone sodium market size accounted for USD 2.85 billion in 2025 and is predicted to increase from USD 2.99 billion in 2026 to approximately USD 4.52 billion by 2035, expanding at a CAGR of 4.80% from 2026 to 2035. The market is driven by the increasing global prevalence of severe bacterial infections.
The US nitrile gloves market size accounted for USD 6.88 billion in 2025 and is predicted to increase from USD 7.38 billion in 2026 to approximately USD 14.22 billion by 2035, expanding at a CAGR of 7.53% from 2026 to 2035. The market growth is attributed to increasing healthcare safety requirements, expanding industrial protection standards, and rising demand for contamination control across pharmaceutical, food processing, and advanced manufacturing industries.
The global US gynecological devices market size accounted for USD 4.17 billion in 2025 and is predicted to increase from USD 4.51 billion in 2026 to approximately USD 9.10 billion by 2035, expanding at a CAGR of 8.12% from 2026 to 2035. The increasing adoption of minimally invasive procedures by healthcare professionals to treat women and technological advancements in hydrothermal ablation devices drive the market growth.
The US cell and gene therapy market size accounted for USD 4.09 billion in 2025 and is predicted to increase from USD 4.74 billion in 2026 to approximately USD 20.00 billion by 2035, expanding at a CAGR of 17.21% from 2026 to 2035. The market is experiencing steady growth due to the rising investments in oncology and rare genetic diseases, strategic alliances between industry players and academic institutions, and personalized solutions for common and rare diseases.
The global neuropharmacology market size accounted for USD 156.80 billion in 2025 and is predicted to increase from USD 168.29 billion in 2026 to approximately USD 311.78 billion by 2035, expanding at a CAGR of 7.20% from 2026 to 2035. The increasing prevalence of neurological diseases, advances in research, and the growing number of clinical trials are key factors driving market growth.
The US pharmaceutical excipients market size accounted for USD 3.08 billion in 2025 and is predicted to increase from USD 3.28 billion in 2026 to approximately USD 5.58 billion by 2035, expanding at a CAGR of 6.12% from 2026 to 2035. The market growth is attributed to rising demand for biologics, specialty drugs, and advanced pharmaceutical formulations requiring high-performance excipients.
The US stroke diagnostic and therapeutic market size accounted for USD 6.40 billion in 2025 and is predicted to increase from USD 6.97 billion in 2026 to approximately USD 15.04 billion by 2035, expanding at a CAGR of 8.92% from 2026 to 2035. The market is driven by the increasing adoption of advanced imaging technologies, an escalating incidence of stroke due to aging, and increasing industrial development.
The US skin repair market size accounted for USD 24.47 billion in 2025 and is predicted to increase from USD 25.98 billion in 2026 to approximately USD 47.43 billion by 2035, expanding at a CAGR of 6.84% from 2026 to 2035. The growing focus on reducing skin problems of the people and the surging deployment of advanced technologies in the cosmetics industry drive the market expansion.
The US dermatology market size accounted for USD 477.75 million in 2025 and is predicted to increase from USD 512.05 million in 2026 to approximately USD 973.78 million by 2035, expanding at a CAGR of 7.38% from 2026 to 2035. The market is driven by the increasing prevalence of chronic skin diseases, growing awareness of skin health, and rising demand for minimally invasive cosmetic procedures.
The US cosmeceuticals market size accounted for USD 16.20 billion in 2025 and is predicted to increase from USD 17.58 billion in 2026 to approximately USD 38.27 billion by 2035, expanding at a CAGR of 8.98% from 2026 to 2035. The market growth is attributed to the rising demand for science-backed skincare, biotechnology-derived ingredients, and personalized beauty solutions.
The US pharmacy automation market size was calculated at USD 1.99 billion in 2025 and is predicted to increase from USD 2.19 billion in 2026 to approximately USD 5.22 billion by 2035, expanding at a CAGR of 10.12% from 2026 to 2035. The market growth is attributed to the rising adoption of intelligent medication management systems, expanding digital healthcare infrastructure, and increasing demand for accurate, high-volume prescription dispensing.
The US electron microscopy market size was calculated at USD 1.40 billion in 2025 and is predicted to increase from USD 1.50 billion in 2026 to approximately USD 2.99 billion by 2035, expanding at a CAGR of 7.88% from 2026 to 2035. The market growth is attributed to rising semiconductor investments, expanding nanotechnology research, and increasing demand for atomic-scale characterization capabilities.
The US brachytherapy market size accounted for USD 345.22 million in 2025 and is predicted to increase from USD 370.79 billion in 2026 to approximately USD 699.86 million by 2035, expanding at a CAGR of 7.32% from 2026 to 2035. The market growth is attributed to rising cancer incidence, increasing adoption of precision radiation therapies, and continuous advancements in brachytherapy technologies.
The global remote neurological monitoring market size was calculated at USD 2.45 billion in 2025 and is predicted to increase from USD 2.81 billion in 2026 to approximately USD 9.69 billion by 2035, expanding at a CAGR of 14.80% from 2026 to 2035. The market is driven by the rising integration of artificial intelligence (AI) and cloud analytics, which enable real-time predictive care and also early detection of neurodegenerative diseases outside traditional hospital settings.
The US active pharmaceutical ingredients market size accounted for USD 41.77 billion in 2025 and is predicted to increase from USD 44.46 billion in 2026 to approximately USD 79.80 billion by 2035, expanding at a CAGR of 6.69% from 2026 to 2035. The increasing demand for precision medicines, along with the technological advancements in the biopharma industry, has driven the market.
The US CAR T-cell therapy market size accounted for USD 2,299.97 million in 2025 and is predicted to increase from USD 2,684.84 million in 2026 to approximately USD 11,510.04 million by 2035, expanding at a CAGR of 17.47% from 2026 to 2035. The market is expanding rapidly due to increasing cancer incidence, growing adoption of personalized medicine, and continuous FDA approvals for new indications and products.
The US infant incubator market size accounted for USD 208.89 million in 2025 and is predicted to increase from USD 224.31 million in 2026 to approximately USD 442.25 million by 2035, expanding at a CAGR of 7.79% from 2026 to 2035. The market is driven by the rising prevalence of preterm births, increasing neonatal intensive care unit (NICU) admissions, advancements in neonatal care technologies, expanding healthcare infrastructure, and growing government investments in maternal and infant healthcare services.
The global CNS drug discovery market size was calculated at USD 9.80 billion in 2025 and is predicted to increase from USD 10.86 billion in 2026 to approximately USD 27.55 billion by 2035, expanding at a CAGR of 10.90% from 2026 to 2035. The rising prevalence of CNS disorders, the integration of AI and ML in drug discovery, and increased government support for clinical trials and funding are significant factors driving market growth.
The US pharmaceutical water market size accounted for USD 7.84 billion in 2025 and is predicted to increase from USD 8.66 billion in 2026 to approximately USD 17.97 billion by 2035, expanding at a CAGR of 8.65% from 2026 to 2035. The market is witnessing substantial growth due to the escalating burden of chronic diseases and the surging demand for high-quality biologics and sterile injectables. This expansion is supported by stringent FDA sterility standards and rapid advancements in water purification technologies, spurring massive investments in pharmaceutical manufacturing infrastructure.
The US biosensors market size accounted for USD 10.87 billion in 2025 and is predicted to increase from USD 11.69 billion in 2026 to approximately USD 20.42 billion by 2035, expanding at a CAGR of 6.51% from 2026 to 2035. The market is driven by the rising prevalence of chronic diseases, increasing demand for point-of-care testing, and advancements in wearable healthcare technologies.
The US bone grafts and substitutes market size accounted for USD 1.31 billion in 2025 and is predicted to increase from USD 01.38 billion in 2026 to approximately USD 2.25 billion by 2035, expanding at a CAGR of 5.56% from 2026 to 2035. Market growth is driven by the increasing prevalence of orthopedic disorders, rising sports injuries, a growing aging population, and expanding demand for minimally invasive surgical procedures.
The US cardiovascular drugs market size accounted for USD 28.42 billion in 2025 and is predicted to increase from USD 29.25 billion in 2026 to approximately USD 37.03 billion by 2035, expanding at a CAGR of 2.68% from 2026 to 2035. The market is witnessing substantial growth, mainly driven by the increasing prevalence of hypertension and heart failure, paired with a high demand for convenient oral medications and next-generation combination therapies that enhance patient compliance.
The US DNA synthesis market size was calculated at USD 1.90 billion in 2025 and is predicted to increase from USD 2.30 billion in 2026 to approximately USD 10.66 billion by 2035, expanding at a CAGR of 18.82% from 2026 to 2035. The growing investments in the biotechnology industry and technological advancements in the genetic engineering sector have accelerated the market expansion.
The US personalized medicine market size was calculated at USD 192.21 billion in 2025 and is predicted to increase from USD 207.15 billion in 2026 to approximately USD 427.17 billion by 2035, expanding at a CAGR of 8.31% from 2026 to 2035. The market is witnessing substantial growth due to the escalating burden of chronic diseases and the high demand for tailored treatments. This growth is supported by NGS and AI integration, spurring research and development in oncology and rare genetic disorders with precise, patient-specific therapies.
The US biotechnology market size accounted for USD 316.41 billion in 2025 and is predicted to increase from USD 361.07 billion in 2026 to approximately USD 1,142.07 billion by 2035, expanding at a CAGR of 13.70% from 2026 to 2035. The market is witnessing substantial growth due to an increasing prevalence of chronic and rare diseases, spurring high demand for precision biologics and gene therapies. Backed by significant research and development investments and FDA approvals, companies are prioritizing targeted platforms that provide highly effective, personalized patient care across critical therapeutic areas.
The US drug discovery market size accounted for USD 26.24 billion in 2025 and is predicted to increase from USD 28.66 billion in 2026 to approximately USD 63.02 billion by 2035, expanding at a CAGR of 9.16% from 2026 to 2035. The market is witnessing substantial growth due to escalating prevalence of chronic conditions, a surging demand for targeted precision therapies, and the integration of AI in preclinical research. This is further supported by significant private and federal research and development investments and robust clinical pipelines across major therapeutic areas.
The global dementia care market size accounted for USD 21.20 billion in 2025 and is predicted to increase from USD 22.97 billion in 2026 to approximately USD 46.97 billion by 2035, expanding at a CAGR of 8.40% from 2026 to 2035. The market is driven by the growing aging population. As life expectancy rises globally, the sheer volume of older adults, who are at the highest risk for neurodegenerative disorders, is leading to an unprecedented increase in dementia diagnoses.
The global stem cell therapy for neurological disorders market size accounted for USD 2.38 billion in 2025 and is predicted to increase from USD 2.81 billion in 2026 to approximately USD 12.67 billion by 2035, expanding at a CAGR of 17.90% from 2026 to 2035. The market is driven by technological advances in stem cell therapy manufacturing, a growing number of clinical trials, and the rising prevalence of neurological disorders.
The US diabetic foot ulcer treatment market size accounted for USD 3.66 billion in 2025 and is predicted to increase from USD 3.87 billion in 2026 to approximately USD 6.58 billion by 2035, expanding at a CAGR of 6.04% from 2026 to 2035. The market is witnessing substantial growth due to the growing diabetic population, along with an aging demographic. The market is further driven by advancements in advanced wound care and regenerative medicine, spurring clinical pipelines for targeted biologics and 3D-bioprinted tissues to improve limb preservation and quality of life.
The US healthcare cloud computing market size accounted for USD 23.58 billion in 2025 and is predicted to increase from USD 27.74 billion in 2026 to approximately USD 117.90 billion by 2035, expanding at a CAGR of 17.46% from 2026 to 2035. The market is witnessing substantial growth due to the rapid digital transformation in healthcare systems, increasing adoption of electronic health records (EHRs), rising demand for scalable data storage, and growing use of AI-enabled analytics to improve patient care, operational efficiency, and data security compliance.